A. Gangemi
Temple University
Internal medicineLung allocation scoreLung transplantationPopulationMedicine
What is this?
Publications 5
#1A. Gangemi (TU: Temple University)H-Index: 1
#2Catherine N. Myers (TU: Temple University)
Last. A. James Mamary (TU: Temple University)H-Index: 9
view all 10 authors...
Abstract Rationale Sarcoidosis progresses to end stage fibrotic lung disease in 10% of patients and may necessitate lung transplantation. Organ allocation is currently determined by the Lung Allocation Score (LAS), but its performance in a sarcoidosis population has not been evaluated. Objectives To determine sarcoidosis-specific wait list mortality and identify predictive factors of death on the transplantation wait list. Methods This was a single-center retrospective study of all sarcoidosis p...
#1Parth Rali (TU: Temple University)H-Index: 2
#2A. Gangemi (TU: Temple University)H-Index: 1
Last. Lisa K. Moores (USU: Uniformed Services University of the Health Sciences)H-Index: 22
view all 5 authors...
The direct-acting oral anticoagulants (DOACs) have been increasingly used over vitamin K antagonists in recent years because they do not require monitoring and have an immediate anticoagulation effect. In general, DOACs have exhibited a better safety profile and noninferiority for prophylaxis and treatment of venous thromboembolism (VTE) and stroke prevention in patients with atrial fibrillation compared with vitamin K antagonists in the non-ICU population; whether this finding holds true in pat...
#1Y. Dotan (St. Luke's University Health Network)
#2J.I. Stewart (TU: Temple University)H-Index: 1
Last. A.J. Mamary (TU: Temple University)H-Index: 1
view all 10 authors...
#1A. Gangemi (TU: Temple University)H-Index: 1
#2C.N. Myers (TU: Temple University)H-Index: 1
Last. A.J. Mamary (TU: Temple University)H-Index: 1
view all 12 authors...
1 CitationsSource
#1A. Gangemi (TU: Temple University)H-Index: 1
#2M. Kousha (St. John's Hospital)
Last. Gerard J. Criner (TU: Temple University)H-Index: 12
view all 13 authors...